MedTrace Logo

Early DHA Supplementation in Very Low Birth Weight Infants

NCT03192839 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 30

Last updated 2019-05-07

No results posted yet for this study

Summary

This clinical trial will evaluate the effects of giving supplements of PUFA to premature infants.

Conditions

  • Prematurity

Interventions

OTHER

Low dose PUFA

Low dose PUFA

OTHER

High dose PUFA

High dose PUFA

OTHER

Placebo

Placebo

Sponsors & Collaborators

  • North Shore Research Institue

    collaborator UNKNOWN

  • Mead Johnson Nutrition

    lead INDUSTRY

Principal Investigators

  • Timothy Cooper, M.D · Mead Johnson Nutrition

Study Design

Allocation
RANDOMIZED
Purpose
OTHER
Masking
TRIPLE
Model
PARALLEL

Eligibility

Max Age
3 Days
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2017-07-01
Primary Completion
2018-07-09
Completion
2018-08-30

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03192839 on ClinicalTrials.gov